Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer

A need exists for seeking effective treatments for castration-resistant prostate cancer (CRPC) in response to its emergence following androgen deprivation therapy as a major clinical problem. In the present study, we investigated the chemopreventive and chemotherapeutic potential of luteolin, a flav...

Descripción completa

Detalles Bibliográficos
Autores principales: Naiki-Ito, Aya, Naiki, Taku, Kato, Hiroyuki, Iida, Keitaro, Etani, Toshiki, Nagayasu, Yuko, Suzuki, Shugo, Yamashita, Yoriko, Inaguma, Shingo, Onishi, Masaya, Tanaka, Yasuhito, Yasui, Takahiro, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Carcinogenesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422625/
https://www.ncbi.nlm.nih.gov/pubmed/31805186
http://dx.doi.org/10.1093/carcin/bgz193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422625/
https://www.ncbi.nlm.nih.gov/pubmed/31805186
http://dx.doi.org/10.1093/carcin/bgz193

Ejemplares similares